Sign in

CIK 0001609809

  • Non-accelerated filer
  • Smaller reporting company

Seres Therapeutics, Inc.

Sign in to watch
Ticker
MCRB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
274326290
Phone
+1 617-945-9626
Business address
200 SIDNEY STREET, CAMBRIDGE, MA, 02139
Former names
Seres Therapeutics, Inc., Seres Health, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$795
in 4 filings, $795 under 10b5-1 plans

Net −$795. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-06-16 Kender Richard N Director Grant or award · Stock Option (right to buy) +23,000 23,000
2021-06-16 Zausner Meryl Director Grant or award · Stock Option (right to buy) +23,000 23,000
2021-06-01 Arkowitz David Chief Financial Officer Grant or award · Stock Options (right to buy) +270,000 270,000
2021-06-01 Arkowitz David Chief Financial Officer Grant or award · Restricted Stock Units +5,000 5,000
2021-05-17 Nutritional Health LTP Fund General Partner LLC 10% owner Other disposition −295,171 2,962,963
2021-02-04 DesRosier Thomas Chief Legal Officer and EVP Grant or award · Stock Option (Right to Buy) +100,000 100,000
2021-02-04 Chapman Marcus Grant or award · Restricted Stock Units +12,000 12,000
2021-02-04 Chapman Marcus Grant or award · Stock Option (Right to Buy) +24,000 24,000
2021-02-04 von Moltke Lisa Grant or award · Stock Option (Right to Buy) +110,000 110,000
2021-02-04 Young Teresa L. Grant or award · Stock Option (Right to Buy) +90,000 90,000
2021-02-04 Shaff Eric D. President, CEO Grant or award · Stock Option (Right to Buy) +350,000 350,000
2021-02-04 Henn Matthew R. Grant or award · Stock Option (Right to Buy) +130,000 130,000
2020-12-01 Henn Matthew R. Exercise or conversion +26,000 $0.71 $18K 38,000
2020-12-01 Henn Matthew R. Exercise or conversion +26,250 $9.89 $260K 64,250
2020-12-01 Henn Matthew R. Exercise or conversion +27,562 $6.01 $166K 91,812
2020-12-01 Henn Matthew R. Sale −55,706 $26.56 $1.5M 36,106
2020-12-01 Henn Matthew R. Sale −26,265 $27.56 $724K 9,841
2020-12-01 Henn Matthew R. Sale −9,841 $28.34 $279K 0
2020-12-01 Henn Matthew R. Exercise or conversion · Stock Option (Right to Buy) −26,000 0
2020-12-01 Henn Matthew R. Exercise or conversion · Stock Option (Right to Buy) −26,250 3,750

Page 22 of 23 · 458 trades